Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
2011 · Journal of Medicinal Chemistry · 592 citations
https://doi.org/10.1021/jm101459g
A
Arne Mørk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
5.2K
Citations
36
h-index
75
i10-index
Arne Mørk is an academic researcher. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Neurotransmitter Receptor Influence on Behavior & Receptor Mechanisms and Signaling. The author has an h-index of 36, co-authored 115 publications.
Papers by this author
worksPharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
2011 · Journal of Pharmacology and Experimental Therapeutics · 265 citations
https://doi.org/10.1124/jpet.111.189068
Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens
2004 · Neuropsychopharmacology · 210 citations
https://doi.org/10.1038/sj.npp.1300516
HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells
2010 · Journal of Neurochemistry · 56 citations
https://doi.org/10.1111/j.1471-4159.2010.06917.x
Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice
2020 · Translational Psychiatry · 16 citations
https://doi.org/10.1038/s41398-020-00914-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat